Bio-Rad closes $1.2B senior notes offering (3.300% 2027 & 3.700% 2032)

BIO-RAD LABORATORIES, INC.

$400M 3.300% notes due 2027 and $800M 3.700% notes due 2032 issued at par.
Net proceeds of approximately $1.186 billion after underwriting discount and expenses.
Proceeds for general corporate purposes, including working capital, capex, and potential M&A.
Joint book-runners: Citigroup Global Markets, Goldman Sachs, J.P. Morgan Securities.
Closing date March 2, 2022; offering pursuant to shelf registration statement on Form S-3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.